Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

70.51USD
23 Jul 2018
Change (% chg)

$1.33 (+1.92%)
Prev Close
$69.18
Open
$69.00
Day's High
$71.00
Day's Low
$69.00
Volume
3,284
Avg. Vol
32,920
52-wk High
$76.29
52-wk Low
$26.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.03 -1.069
FY 2017 Dec '17 0.28 -0.925
Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.11 0.20 0.00 0.72
Quarter Ending Dec-18 5 0.31 1.14 0.00 0.85
Year Ending Dec-18 6 2.49 10.00 0.00 2.71
Year Ending Dec-19 5 2.12 10.00 0.00 1.99
Earnings (per share)
Quarter Ending Sep-18 5 -0.89 -0.59 -1.08 -0.69
Quarter Ending Dec-18 5 -0.91 -0.59 -1.12 -0.71
Year Ending Dec-18 6 -3.70 -2.94 -4.29 -2.87
Year Ending Dec-19 5 -3.70 -1.80 -4.71 -3.97
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 217.69 33.34
P/E High - Last 5 Yrs. -- 284.50 47.12
P/E Low - Last 5 Yrs. -- 96.76 24.95
Beta 0.70 0.76 0.81
Price to Sales (TTM) 2,119.82 256.17 8.11
Price to Book (MRQ) 7.06 21.19 4.23
Price to Tangible Book (MRQ) 7.31 27.03 6.21
Price to Cash Flow (TTM) -- 128.89 22.22
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.39
Payout Ratio(TTM) -- 84.35 47.39

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -92.47 33.43 4.76
Sales (TTM) vs TTM 1 Yr. Ago -68.12 147.14 12.32
Sales - 5 Yr. Growth Rate -37.14 30.77 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.92 -79.61 48.99
EPS (TTM) vs TTM 1 Yr. Ago -55.23 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.97
Capital Spending - 5 Yr. Growth Rate 26.46 42.60 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 20.55 6.63 3.63
LT Debt to Equity (MRQ) 0.00 24.46 13.08
Total Debt to Equity (MRQ) 0.00 28.66 17.18
Interest Coverage (TTM) -- -154.53 35.06

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.90 55.23
Gross Margin - 5 Yr. Avg. -- 53.43 53.18
EBITD Margin (TTM) -10,319.65 -- --
EBITD - 5 Yr. Avg -473.06 -182.15 15.61
Operating Margin (TTM) -10,383.98 -964.42 -0.70
Operating Margin - 5 Yr. Avg. -478.97 -195.77 10.75
Pre-Tax Margin (TTM) -11,863.66 -858.38 1.18
Pre-Tax Margin - 5 Yr. Avg. -477.57 -200.51 10.87
Net Profit Margin (TTM) -11,815.60 -849.10 -2.12
Net Profit Margin - 5 Yr. Avg. -474.67 -198.30 7.23
Effective Tax Rate (TTM) -- 14.86 20.83
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 10,144 23,539,371 740,084,415
Net Income/Employee (TTM) -1,198,595 -1,115,845 86,307,671
Receivable Turnover (TTM) 5.76 17.88 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.13 -2.23 10.36
Return on Assets - 5 Yr. Avg. -43.95 2.95 11.03
Return on Investment (TTM) -55.80 -3.65 13.18
Return on Investment - 5 Yr. Avg. -52.07 2.79 14.26
Return on Equity (TTM) -55.80 -5.62 15.09
Return on Equity - 5 Yr. Avg. -52.07 -4.53 15.57
  1 Year 3 Year 5 Year
Sales % -66.78 -52.17 -37.14
EPS (TTM) % -42.88 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 3.59 1.86 72 45
13 Week 8.42 3.32 63 62
26 Week 34.25 34.66 84 69
52 Week 147.51 118.50 91 85
YTD 72.69 64.79 88 86
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 91.66%
# of Holders: 113
Total Shares Held: 38,111,544
3 Mo. Net Change: -234,261
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 6
# Reduced Positions: 4
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.